EAM
BLTE

Eventide Asset Management’s Belite Bio BLTE Stock Holding History

Eventide Asset Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2M Buy
390,829
+33,179
+9% +$5.09M 0.8% 37
2026
Q1 		$57M Sell
357,650
-25,441
-7% -$4.28M 0.94% 31
2025
Q4 		$61.3M Buy
383,091
+187,779
+96% +$22.2M 0.96% 27
2025
Q3 		$14.5M Buy
+195,312
New +$12.8M 0.24% 114

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Eventide Asset Management's BLTE Position: Q2 2026 in Review

Eventide Asset Management increased its Belite Bio (BLTE) stake by 9.3% in Q2 2026, buying an estimated $5.09M and bringing the position to 390,829 shares worth $60.2M. The position accounts for 0.8% of the portfolio, ranked #37.

Eventide Asset Management first reported a position in BLTE in Q3 2025 and has held it in 4 quarters since. The position peaked at $61.3M in Q4 2025. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Eventide Asset Management held 390,829 shares of Belite Bio worth $60.2M as of Q2 2026.
  • Eventide Asset Management bought 33,179 Belite Bio shares in Q2 2026, an estimated $5.09M.
  • Belite Bio made up 0.8% of Eventide Asset Management's portfolio in Q2 2026, its #37 holding.
  • Eventide Asset Management first reported a position in Belite Bio in Q3 2025 and has held it in 4 quarters since.
  • Eventide Asset Management's Belite Bio position peaked at $61.3M in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.